Evidence map›Paper›PMID 35065358›Full record

ArticleJournal of infection and public health2022

Association between COVID-19 morbidity, mortality, and gross domestic product, overweight/ obesity, non-communicable diseases, vaccination rate: A cross-sectional study.

Kuat Oshakbayev, Zulfiya Zhankalova, Meruyert Gazaliyeva, Khalit Mustafin, Gulnara Bedelbayeva, Bibazhar Dukenbayeva, Nurzhan Otarbayev, Attila Tordai

Abstract read
In one paragraph

Article in Journal of infection and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Observational
  5. Neuroticism predicts national vaccination rates across 56 countries.Current psychology (New Brunswick, N.J.) · 2023
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kuat OshakbayevNational Research Oncology Center, Metabolic Syndrome Department, Street Kerey Zhanibek Khans, 3, Nur-Sultan (Astana) 010000, Kazakhstan; ANADETO Medical Center, Street Kerey Zhanibek khans, 22, Nur-Sultan (Astana) 010000, Kazakhstan. Electronic address: okp.kuat@gmail.com.
Zulfiya ZhankalovaAsfendiyarov Kazakh National Medical University, Faculty of Postgraduate Education, Department of General Medical Practice, #1 Street Tole Bi, 94, Almaty 050000, Kazakhstan. Electronic address: zulfiya-zhankalo@mail.ru.
Meruyert GazaliyevaMedical University Karaganda, Faculty of Internal Medicine, Street Gogol, 40, Karaganda 100000, Kazakhstan. Electronic address: gazaliyeva@yandex.ru.
Khalit MustafinNational Center of neurosurgery, Department Surgery, Turan Ave 34/1, Astana, Kazakhstan. Electronic address: halit.mustafin@yandex.ru.
Gulnara BedelbayevaAsfendiyarov Kazakh National Medical University, Faculty of Postgraduate Education, Department of General Medical Practice, #1 Street Tole Bi, 94, Almaty 050000, Kazakhstan. Electronic address: bedelbaeva@mail.ru.
Bibazhar DukenbayevaMedical University Astana, Faculty of Pathology and Forensic Medicine, Beybitshilik street 49A, Nur-Sultan (Astana) 010000, Kazakhstan; ANADETO Medical Center, Street Kerey Zhanibek khans, 22, Nur-Sultan (Astana) 010000, Kazakhstan. Electronic address: dukenbaeva74@gmail.com.
Nurzhan OtarbayevLLP 'Medicare', Member of the Supervisory Board, LLP 'Meirim', Medical Consultant, Nur-Sultan (Astana), Kazakhstan. Electronic address: otarbaev@rambler.ru.
Attila TordaiSemmelweis University, Dept. Pathophysiology, H-1088 Budapest, Vas u. 17, Hungary. Electronic address: tordai.attila@med.semmelweis-univ.hu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe spread of COVID-19 depends on a lot of social and economic factors. THE

aimto study the influence of country's gross domestic product, population prevalence of overweight/ obesity, NCD mortality, and vaccination on COVID-19 morbidity and mortality rates.

methodsA cross-sectional study with two phases: correlation-regression interrelations in 1) all world countries; 2) all world non-island countries. The study includes the following data from 218 world countries: COVID-19 morbidity/mortality rates, GDP per capita, the prevalence of overweight/ obesity, NCD mortality among adults (both sexes), people fully vaccinated against COVID-19.

resultsAn average percentage of the prevalence of overweight among adults in world countries by 2019 was 47.31 ± 15.99%, obesity 18.34 ± 9.64%, while the prevalence by 2016 were 39% and 13%, respectively. Overweight and obesity among adults during three years grew by 21.2% and 40.8%, respectively. Data from the world countries provide significant correlations (p < 0.0001) between COVID-19 morbidity, and: GDP (r = 0.517), overweight (r = 0.54), obesity (r = 0.528), NCD mortality (r = 0.537); COVID-19 mortality, and: GDP (r = 0.344), overweight (r = 0.514), obesity (r = 0.489), NCD mortality (r = 0.611); GDP, and: overweight (r = 0.507), obesity (r = 0.523), NCD mortality (r = 0.35), fully vaccinated people (r = 0.754). An increase in fully vaccinated people, from 3% to 30% of world population, decreases new confirmed COVID-19 cases, although the dependence was not significant (p = 0.07). Data from non-island world countries provides more highly significant correlations (p < 0.0001) between COVID-19 morbidity, and: GDP (r = 0.616), overweight (r = 0.581), obesity (r = 0.583); COVID-19 mortality, and: GDP (r = 0.43), overweight (r = 0.556), obesity (r = 0.539); GDP, and: overweight (r = 0.601), obesity (r = 0.633). The differences of correlation coefficients between data of 176 world countries and data of 143 world non-island countries were not significant (Z-scores<1.29; p > 0.05).

conclusionThe study provides evidence of a significant impact of overweight/obesity prevalence on the increase in COVID-19 morbidity/mortality. Countries with higher GDP have a high overweight/obesity prevalence and possibility to get vaccinated.

Indexed as

COVID-19Noncommunicable DiseasesAdultCross-Sectional StudiesFemaleGlobal HealthGross Domestic ProductHumansMaleObesityOverweightPrevalenceSARS-CoV-2VaccinationA cross-sectional studyCOVID-19 mortality/morbidityGross domestic productNon-communicable diseasesOverweight/obesity

Identifiers

PMID35065358
PMCPMC8759097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.